Loading company…
Magellan Biologics develops protein expression products, including its CHO 4Tx® transfection system.
Magellan Biologics sells CHO 4Tx® kits and related materials for protein expression in Chinese Hamster Ovary cells, serving research, pharmaceutical, and biotechnology organizations. Founded in 2014 and based in Portugal, it was majority-acquired by ARCHIMED in 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in